InnoCan Pharma (XCNQ:INNO) Total Long-Term Liabilities : C$0.01 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is InnoCan Pharma Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. InnoCan Pharma's Total Long-Term Liabilities for the quarter that ended in Dec. 2023 was C$0.01 Mil.

InnoCan Pharma Total Long-Term Liabilities Historical Data

The historical data trend for InnoCan Pharma's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Total Long-Term Liabilities Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Long-Term Liabilities

Get a 7-Day Free Trial

0.05

0.03

0.01

InnoCan Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Long-Term Liabilities	Get a 7-Day Free Trial															0.03	0.04	0.03	0.02	0.01

InnoCan Pharma Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

InnoCan Pharma Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma (XCNQ:INNO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

INNPF:USA IP4:Germany

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

InnoCan Pharma (XCNQ:INNO) Headlines

From GuruFocus

Innocap, Inc. Year End Message To Shareholders

By PRNewswire PRNewswire • 12-14-2020

Innocap, Inc. Current Activities - Salvage Ship Has Departed Singapore For Recovery Operations

By Marketwired Marketwired • 06-28-2018

Innocap, Inc.'s Current Activities

By Marketwired Marketwired • 05-24-2018

President of Innocap, Inc. is in Singapore

By GlobeNewswire GlobeNewswire • 05-03-2018

Unique Logistics Holdings, Inc. and Innocap, Inc. Complete Reverse Merger and Financing

By PRNewswire PRNewswire • 10-27-2020

President of Innocap, Inc. is in Singapore

By Marketwired Marketwired • 05-03-2018